Skip to main content
TipRanks
Go Ultimate75% OFF

Aubrey Rankin Insider Profile

4 Followers

Aubrey Rankin, former Director at Revance Therapeutics, holds 570.00K shares in Revance Therapeutics (Ticker: RVNC).

Aubrey Rankin's Trading History

RVNC
Revance Therapeutics
Mar 17, 2022―Uninformative Sell21.66K$2.08M
RVNC
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 17, 2022Uninformative Sell$21.66K1,372$15.79―
Dec 06, 2021Informative Buy$432.60K30,000$14.42+49.00%
Aug 17, 2021Uninformative Sell$375.42K14,313$26.22―
Jul 30, 2021Informative Sell$603.00K20,000$30.15+49.80%
Jul 30, 2021Uninformative Sell$1.03M34,332$30.00―

You May Also Like

Aubrey Rankin insider profile FAQ

What is the percentage of profitable transactions made by Aubrey Rankin?
The percentage of profitable transactions made by Aubrey Rankin is 100%.
What is the average return per transaction made by Aubrey Rankin?
The average return per transaction made by Aubrey Rankin is 49.40%.
What stocks does Aubrey Rankin hold?
Aubrey Rankin holds: RVNC stocks.
What was Aubrey Rankin’s latest transaction?
Aubrey Rankin’s latest transaction was an Uninformative Sell of $21.66K.
What was Aubrey Rankin's most profitable transaction?
Aubrey Rankin’s most profitable transaction was an Informative Sell of RVNC stock on July 30, 2021. The return on the trade was 49.80%.
What is Aubrey Rankin's role in Revance Therapeutics?
Aubrey Rankin's role in Revance Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.